[1]
“PAC1 RECEPTOR SIGNALING IN ESTABLISHED NEUROPATHIC PAIN: MOLECULAR MECHANISMS, NEUROINFLAMMATORY PATHWAYS, AND CENTRAL SENSITIZATION FOR TARGETED CHRONIC PAIN THERAPEUTICS”, Biosci. Insights., vol. 3, no. 3, pp. 981–1009, Oct. 2026, Accessed: Nov. 13, 2026. [Online]. Available: https://www.biosciinsights.com/index.php/BI/article/view/308